Objective: In humans, the existence of an anterior periaortic fat pad (AFP) containing parasympathetic ganglia has been described in the aortopulmonary window. Changes in the autonomic nervous system (ANS) tone can lead to postoperative atrial fibrillation (POAF). The AFP is usually removed during coronary bypass grafting (CABG) to fully expose the aortic root. The purpose of this study was to evaluate the influence of AFP removal during CABG on the ANS tone, incidence of POAF, hospital stay, and in-hospital morbidity and mortality. Methods: A total of 215 patients were randomized in this prospective, double-blind trial to either removal (n = 107) or maintenance (n = 108) of the AFP during their first CABG. All patients underwent continuous telemetry monitoring after surgery. They underwent at least 1-h Holter monitoring on the second postoperative day. Heart rate variability measurements of both time-domain and frequency-domain analysis were included. POAF was defined as AF for more than 5 min or causing hemodynamic instability. Results: The mean age was nearly 58 years, and 76% were male. There was no difference in the incidence of POAF between the retained and removed AFP groups (19.3% vs 17%, respectively; P = 0.664, odds ratio = 1.16). Mean heart rate and heart rate variability parameters, in-hospital stay, and postoperative morbidity and mortality were similar in both groups. Conclusions: Removal of the AFP during CABG has no significant effect on the incidence of POAF, ANS tone, and postoperative morbidity or mortality. #
Introduction
Atrial fibrillation is one of the most common complications after coronary artery bypass grafting (CABG) with an incidence ranging from 20% to 45% [1] . Postoperative atrial fibrillation (POAF) has a multifactorial pathogenesis. Old age, reduced left ventricular function, atrial abnormalities, and pre-existing electrocardiogram (ECG) abnormalities, intraoperative stress, including reperfusion, inflammation, hemostasis, and increased excitotoxicity, all have been implicated [2, 3] . However, the precise contribution of each risk factor, the pathophysiologic mechanisms, and the role of the cardiovascular autonomous nervous system (ANS) in the postoperative patient are still widely controversial [4] . Imbalance in the ANS after open heart surgery, especially with extracorporeal circulation, has been proposed as a major risk factor for the occurrence of POAF [5, 6] . Considering this, manipulations on the ANS have been evaluated for AF prevention in both animals and patients [7] [8] [9] . A series of studies in dogs demonstrated the existence of discrete cardiac fat pads in which cardiac ganglia are located [7, 10, 11] . Major epicardial fat pads in the dog are right PV ('sinus nodal') fat pad, inferior vena cava-left atrium (IVC-LA) ('atriventricular (AV) nodal') fat pad, and superior vena cava-aorta (SVC-Ao). In humans, an anterior fat pad (AFP) similar to the canine SVC-Ao fat pad was discovered and located on the anterior surface of the atria between the aorta and pulmonary artery [7] . In canines, the AFP is the conduit of most efferent parasympathetic nerve fibers en-route to the sinus and AV nodal fat pads [7] . Nerve stimulation of the AFP in canines increases atrial cycle length, slows the atrioventricular conduction time, and shortens the atrial effective refractory period (A-ERP) [7, 8] . Shortening the A-ERP decreases the wavelength of atrial excitation wave fronts and increases the chances of developing AF. Catheter ablation of the AFP in two canine studies has been shown to prevent or attenuate A-ERP shortening with nerve stimulation and also the inducibility of AF [7, 8] .
The AFP is frequently removed during cardiothoracic surgery patients to fully expose the aortic root [12] [13] [14] [15] . Extrapolation of canine data suggests that AFP excision during cardiothoracic surgery would reduce the risk of developing POAF [16, 17] . A limited number of studies have evaluated the effect of AFP maintenance or removal on the incidence of POAF with conflicting results [7, 8, [12] [13] [14] . Recently, White et al. [15] , in a single-blinded, randomized trial did not find any relationship between the AFP and the incident of POAF. We present our study, with a double-blind design, and a primary purpose of reevaluating the effect of AFP removal during CABG on the ANS and the incidence of POAF. Our secondary aim was to evaluate the impact of AFP removal on various postoperative complications.
Methods

Patient population and study design
Between October 2008 and December 2009, 448 patients scheduled for their first isolated CABG were screened for enrolment in the study. They were excluded from the study in case of age below 50 years (n = 35), presence of concomitant valvular disease of more than mild degree (n = 96), a documented history of AF or atrial flutter before the operation (n = 24), or history of thyroid dysfunction, or under treatment of thyroid disorders (n = 0). Seventy-eight patients refused to participate in the study (Fig. 1) . Prophylactic antiarrhythmic drugs, other than beta-blockers (amiodarone, sotalol, and steroidal and non-steroidal antiinflammatory agents), were not given before operation.
The study protocol was approved by our Institutional Committee on Human Research and complies with the provisions of the Declaration of Helsinki. A written informed consent was obtained from each patient.
Overall, 215 patients were randomized in this prospective, double-blind trial to either removal (n = 107) or maintenance (n = 108) of the AFP during CABG. A nurse in the operating room was responsible for the randomization, and the patients or physicians caring out the study or collecting data were completely blinded to treatment group allocations. All demographics, non-cardiac and cardiac disease histories, coronary risk factors, patterns and numbers of major epicardial coronary artery involvement, number of vein and arterial grafts, surgical method, postoperative complications, in-hospital stay, and morbidity and mortality data were collected.
Surgical techniques
All patients underwent standard median sternotomy CABG. Patients undergoing other types of cardiac surgery, including minimally invasive surgery or valve replacement, were excluded. All operations were performed by the three surgeons participating in the study (N.S., A.J., and Ab.A.), using either off-pump or on-pump CABG. The anesthetic techniques, including premedication, induction, maintenance, and reversal of anesthesia, were similar in both groups. If the patient was randomized to AFP removal, it was excised as completely as possible before CABG by surgical scissors and forceps from around the ascending aorta and the main pulmonary artery. Thereafter, in the on-pump group, standard cardiopulmonary bypass was initiated between the right atrium and the base of the ascending aorta using Stockert S-III roller pump bypass machine (Stockert Instruments GmbH, Munchen, Germany). Moderate systemic hypothermia (about 32 8C) was maintained during bypass by antegrade and retrograde tepid blood cardioplegia for myocardial protection in all cases. In off-pump patients, the octopus stabilizer (Medtronic, Minneapolis, USA) was used during normothermia. For anastomosing the obtus marginalis branches of the left circumflex artery, the starfish stabilizer (Medtronic, Minneapolis, USA) was also used in some patients. Systemic rewarming was done during the final anastomosis and weaning from the bypass was attempted upon reaching relative normothermia (about 36 8C).
Postoperative care
All patients underwent continuous telemetry monitoring after surgery. All rhythm strips were reviewed and recorded. Two experienced cardiologists (Ay.A. and B.S.), blinded to the patient's randomization group, analyzed all arrhythmias, their duration, time of occurrence, and treatments and collected study data. All patients undergoing CABG received standard care including beta-blockers, angiotensin-converting enzyme inhibitor/angiotensin receptor blockers (ACEI/ ARBs), and statins after surgery, unless contraindicated. None of the patients were given pharmacoprophylaxis to prevent AF. We tried to maintain serum potassium level between 4.5 and 5 meq l À1 , serum magnesium level between 1.5 and 2 meq l À1 , PaO 2 (partial pressure of oxygen in the blood) > 80 mmHg, and PaCO 2 (partial pressure of carbon dioxide in the blood) < 40 mmHg in all patients. Intraoperatively, AF was treated by correcting any electrolyte or acid-base imbalance followed by synchronized direct current cardioversion. Postoperatively, serum potassium, magnesium, PaO 2 , and PaCO 2 were checked during each episode of AF and corrected before initiating further treatment. Patients who were hemodynamically stable were treated with intravenous amiodarone. Immediate direct current (DC) cardioversion was performed in patients, who were hemodynamically unstable.
Heart rate variability (HRV)
Holter monitors were placed on patients for at least 1 h on the second postoperative day. They were attached by a trained technician to patients in a supine position at a similar time each day, before noon. Patients experiencing POAF at the scheduled time were excluded. Holter images were scanned and analyzed with the AB-180R Holter monitoring system (Advanced Biosensor, USA) after being manually edited to eliminate ectopic beats and noise signals by an electrophysiologist (B.K.), carrying out the study. HRV measurements of both time-domain (the SD of normal-to-normal time duration between two consecutive R waves (SDNN)) and frequency-domain analysis were included. The frequency-domain analysis focused on highfrequency components (related to parasympathetic effect) and low-frequency components (governed by both sympathetic and parasympathetic effects). If any patient(s) had AF within the analysis period, they would be excluded before between-group statistical comparison. Mean heart rates were also determined and analyzed from Holter data.
Definitions 2.5.1. POAF
More than 5 min of AF or hemodynamically significant AF (resulting hypotension or heart failure) requiring active intervention.
Cerebrovascular accident
The development of a stroke (documentation by an attending neurologist of a focal deficit lasting more than 24 h, with confirmation of cerebral infarction by brain computed tomography or magnetic resonance imaging) or transient ischemic attack (documentation of a focal neurological deficit lasting for <24 h).
Sustained ventricular arrhythmia
Monomorphic ventricular tachycardia lasting at least 30 s or requiring treatment for termination or occurrence of polymorphic ventricular tachycardia or ventricular fibrillation after surgery.
Perioperative myocardial infarction
Increases of biomarkers greater than five of the normal reference range during the first 72 h following CABG, when associated with the appearance of new pathological Q-waves or new left bundle branch block (LBBB), or angiographically documented new graft or native coronary artery occlusion, or imaging evidence of new loss of viable myocardium.
Postoperative heart failure
Occurrence of inspiratory rales in lung auscultation or pulmonary congestion on postoperative chest X-ray or requiring I.V. inotropes for >30 min, with a dose >5 mg kg À1 min À1 .
Statistical analysis
Variables were expressed as mean AE SD and percentage. Differences between groups for continuous variables were examined by the independent Student's t-test for approximately normally distributed data; otherwise, the MannWhitney U test was used. The Kolmogorov-Smirnov test and Q-Q plot were performed to check the normality of distributions. The chi-square test (or Fisher's exact test if applicable) was used for categorical variables. Two-tailed P < 0.05 was considered significant. Odds ratios (ORs) were calculated and results were presented as ORs with 95% confidence intervals (CIs). Baseline characteristics and exercise variables, if found to be univariate predictors of POAF, would be entered into multivariate models for each end point. Statistical Package for Social Sciences (SPSS) 13.0 software (SPSS Inc., Chicago, IL, USA) was used for data storage and analysis.
Results
Of 448 screened eligible patients, 215 (mean age 58.33 AE 10.55 years, 76% male) fulfilled the inclusion criteria and underwent randomization (Fig. 1 ).
There were no significant differences in demographics, histories of heart failure, myocardial infarction, chronic lung disease, important atherosclerotic risk factors also known to predispose to AF, left ventricular function, extent of coronary artery involvement, the anesthetic technique, cardioplegia type, number of venous and arterial grafts, use of off-pump cardiopulmonary bypass, and in-hospital morbidity or mortality between groups (Table 1) .
Both groups were also well matched according to pre-and postoperative medication use. More than 90% of patients received beta-blockers, ACEI/ARBs, and statins after surgery as standard care in our surgical intensive care unit (ICU) ( Table 2) .
Involvement of any major epicardial coronary artery had no significant effect on the incidence of POAF (Table 3) .
Almost all of the AF episodes occurred in the first three postoperative days. The incidence of POAF was statistically similar in the retained (21 patients) and removed (17 patients) groups (P = 0.66; OR = 1.16).
Mean heart rate (88.5 AE 13.7 vs 87.4 AE 17.6, P = 0.76) and HRV measurements including SDNN (88.8 AE 79.9 vs 71.0 AE 54.5, P = 0.30), low frequency (LF) domain (100.6 AE 35.2 vs 112.7 AE 51.6, P = 0.22) and high frequency (HF) domain (147.9 AE 58.0 vs 144.0 AE 49.3, P = 0.74) were similar between groups (Table 4 ).
Discussion
In the current study, AFP removal had no significant impact on the incidence of POAF and the ANS tone, measured by HRV parameters. Previous studies have reported a favorable effect of AFP maintenance on the incidence of POAF [12, 13] . Cummings et al. [12] were the first to report the positive impact of maintaining the AFP in decreasing POAF in humans. This 55-patient randomized study was primarily aimed at assessing the parasympathetic activity of the AFP by direct nerve stimulation. All patients received only on-pump bypass and had an 81% reduced POAF when the AFP was maintained. It is unknown whether this represents a reliable conclusion or whether chance appears to be a more likely explanation for the positive findings due to a small sample size. Although, Davis et al. [13] , in their first randomized single-blind pilot study (131 patients), showed the favorable effect of retaining the AFP during surgery on POAF incidence, the result was not confirmed in their latter non-randomized extension study (189 more patients) [14] .
Our study design and results were more similar and consistent with White et al. [15] , who also recently reported a neutral effect of AFP maintenance on POAF incidence, but with a relatively preserved parasympathetic tone. In their study, four predictors for POAF were found including age > 70 years, history of AF, mitral regurgitation, and beta-blocker intolerance. Amiodarone prophylaxis and the use of high dose non-steroidal anti-inflammatory agents were associated with reduced risk of POAF. We tried to eliminate these confounding factors in POAF occurrence by not including antiarrhythmic prophylactic drugs, other than beta-blockers (amiodarone, sotalol, and steroidal and non-steroidal antiinflammatory agents) before surgery and excluding those with a history of AF/flutter or concomitant valvular disease patients with more than mild severity. We also blinded the cardiothoracic surgeons to patient allocation, minimizing the impact of their decision on retaining the AFP. Although dissection of the AFP is considered usual practice, the surgeons involved did not have any difficulty retaining the AFP for this study.
More than 90% of our patients received beta-blockers, ACEI/ARBs, and statins after surgery, all of which could have had an impact on POAF by reducing the sympathetic tone (both beta-blockers and statins) [18] and their antiinflammatory effects (statins and steroidal or non-steroidal anti-inflammatory agents) [19] .
Although the majority of the extrinsic cardiac autonomic nerves traverse the periadventitial connective tissue and fat pads surrounding the aortic root, SVC, and the pulmonary artery to reach the heart, a lesser but significant amount of autonomic nerves reaches the heart along the pulmonary veins and IVC, as branches from the tracheoesophageal autonomic supply and as direct branches from thoracic segments [20] . On the other hand, the intrinsic cardiac ANS contains a network of autonomic ganglionated plexi (GPs) and extensive interconnecting neurons and axons. Functional and clinical human studies indicate that disruption of the GPs has the potential for enhancing electrical inhomogeneity, leading to arrhythmias [7, 12] . Conversely, selective ablative strategies targeting the GPs have been presented by some centers as a useful adjunct to pulmonary vein isolation in the treatment of AF [21] . These mixed results undoubtedly reflect our incomplete understanding of the roles of the intrinsic ANS in regulating electrical activity of the heart. Hou et al. [22] have shown elegantly in canine models that ablation of the integration centers should be deferred until after subordinate GPs have been identified and ablated, if effective parasympathetic denervation is to be achieved. This could probably be an explanation for our results that simply removing the AFP might not be enough for producing a clinically significant imbalance in the intrinsic cardiac ANS, which, as mentioned before, has extensive neuronal and axonal interconnections.
Limitations
The main message of our study was that the groups were not significantly different in terms of the most important parameters under investigation. This does not mean, however, that there was no difference. The lack of significance might be mainly a consequence of an insufficient number of patients. Considering this limitation and the relatively wide CIs may indicate that the results must be interpreted cautiously and further research is needed for a decisive conclusion. The second limitation is that we could not be sure if complete removal of the AFP has occurred because we did not use systematic nerve stimulation and did not perform histopathological examination on the excised tissues [7, 8, 12] . Theoretically, this can cause residual parasympathetic activity and confound the results, but Cummings et al. [12] performed nerve stimulation in all patients in whom the AFP was dissected, and in none of them could they prolong the sinus cycle rate. Therefore, it is unlikely that this limitation may have a significant effect on our results. Third, we used a short period for Holter monitoring. Although HRV increases with the length of the recording [23] , the results of short-term recordings correlate well with 24-h recordings and are suitable for measuring changes over time [24] . Furthermore, the prognostic value of short-term Holter recordings has been demonstrated for traditional HRV parameters [25] .
Conclusions
Removal of the AFP during CABG had no significant effect on the incidence of POAF, ANS tone, and postoperative morbidity or mortality. This might be due to a minimal effect on ANS balance when only one major fat pad is excised.
